Phusis Therapeutics, Inc.
San Diego, CA Doing business as Phusis Therapeutics Inc.
- UEI
- JGZFBDAL61C4
- CAGE
- 5KGW3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6019 Folsom Dr, La Jolla, CA 92037, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses -… | National Cancer Institute | $2,085,765 | |
| Targeting ERK5 for colorectal cancer therapy | National Cancer Institute | $752,435 | |
| Inhibiting multi-functional aldoa for cancer therapy | National Cancer Institute | $4,192,845 | |
| Inhibiting PLEKHA7 for mutant kras therapy | National Institutes of Health | $225,000 | |
| Targeting mutant kras for cancer therapy | National Institutes of Health | $287,434 |
SBA capabilities narrative
research, drug discovery and development
Quick answers
What is Phusis Therapeutics, Inc.'s UEI?
Phusis Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is JGZFBDAL61C4.
What is Phusis Therapeutics, Inc.'s CAGE code?
Phusis Therapeutics, Inc.'s CAGE code is 5KGW3.
What is Phusis Therapeutics, Inc.'s primary NAICS code?
Phusis Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Phusis Therapeutics, Inc. located?
Phusis Therapeutics, Inc.'s physical address in SAM.gov is 6019 Folsom Dr, La Jolla, CA 92037, USA.
Is Phusis Therapeutics, Inc. registered in SAM.gov?
Yes. Phusis Therapeutics, Inc.'s SAM.gov registration is active through April 10, 2027.
What is Phusis Therapeutics, Inc.'s most recent federal award?
Phusis Therapeutics, Inc.'s most recent federal grant award is Clinical evaluation of a novel AKT/PDK1 inhibitor, PHT-427, for the treatment of multi-field actinitc keratoses -… (R44CA306740), from National Cancer Institute, on September 15, 2025.
On GovTribe
See Phusis Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors